BP BALKAN PHARMACEUTICALS
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

BP BALKAN PHARMACEUTICALS Trademark

Serial Number: 79272941 • Registration: 6166331

BP BALKAN PHARMACEUTICALS is a trademark filed by EURO MAST INDUSTRIES S.R.L., societate comerciala on October 1, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

EURO MAST INDUSTRIES S.R.L., societate comerciala

Str. Sfîntul Nicolae nr. 4, municipiul R

Entity Type: 99

Trademark Details

Filing Date

October 1, 2019

Registration Date

October 6, 2020

Published for Opposition

July 21, 2020

Goods & Services

Pharmaceutical, medical and veterinary products, namely, products for treating digestive maladies and for affecting metabolism namely, antacids, antiulcerous preparations, antiflatulence preparations; antispastics, anticolinergics, antipropulsives; antivomitive and antinauseants, antidiarrheals; digestive aids, namely, food enzyme and dietary supplements; metabolic aids, namely, stanozolol, methandienone, mesterolone, oxandrolone and nandrolone; products for treating the liver, namely, lipotropics; products for treating disorders and illnesses of blood, haematopoetic organs- and the heparin group, namely, platelet antiaggregants; products for treating disorders and illnesses of the cardiovascular system and for providing heart therapy, namely, diuretics, peripherical vasodilators; blockers, namely, bisoprolol, pantoprazole, famotidine and naltrexone; products that act on the renin-angiotensin system, namely, ramipril, lizinopril, enalapril and captoprile; pharmaceuticals, namely, lipid lowering agents; genital-urinary system and sexual hormones, sexual and modulator hormones of the genital system, genital system medications; systemic hormonal preparations; antiinfectious products for systemic use, namely, ofloxacine, metronidazole, acyclovir, amoxaciline and furaciline; antineoplastic agents and immunomodulators; products for treating the skeletal muscle system, namely, antiinflammatory and antirheumatic non-steroids; products for treating the nervous system, namely, anesthetics, anticonvulsants, antiemetics, antiparkinson agents, CNS stimulants, muscle relaxants, narcotic analgesics, nonnarcotic analgesics, and sedatives; antiparasitics; products for treating the breathing pathway, namely, antiasthmatics, systemic antihistamines; sanitary products for medical use, namely, absorbent products for personal health care and hygiene, medical disinfectant liquids, wipes, sprays and soaps

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 6, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 1, 2021 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Jan 28, 2021 XXSS
GENERIC MADRID TRANSACTION CREATED
Jan 28, 2021 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 6, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 6, 2020 R.PR
NOTIFICATION PROCESSED BY IB
Jul 31, 2020 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 21, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 21, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 15, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 15, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 1, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 17, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 20, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 19, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 19, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 24, 2020 GNRN
NON-FINAL ACTION E-MAILED
Apr 24, 2020 GNRT
NON-FINAL ACTION WRITTEN
Apr 24, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 26, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 26, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 26, 2020 TROA
REFUSAL PROCESSED BY IB
Feb 22, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 5, 2020 RFCS
REFUSAL PROCESSED BY MPU
Feb 5, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 11, 2020 RFCR
NON-FINAL ACTION WRITTEN
Jan 10, 2020 CNRT
NON-FINAL ACTION WRITTEN
Jan 10, 2020 CNRT
ASSIGNED TO EXAMINER
Jan 3, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 6, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 2, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 28, 2019 REPR